Correction: Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry.

Autor: Chelysheva E; National Medical Research Center for Hematology, Moscow, Russian Federation. denve@bk.ru., Apperley J; Centre for Haematology, Imperial College London, London, UK., Turkina A; National Medical Research Center for Hematology, Moscow, Russian Federation., Yassin MA; Department of Medical Oncology/ Hematology Section, National Centre For Cancer Care & Research, Doha, Qatar., Rea D; Service d'hématologie Adulte and FiLMC Hôpital Saint-Louis, Paris, France., Nicolini FE; Hematology department and INSERM 1052 CRCL, Centre Léon Bérard, Lyon, France., Barraco D; Division of Hematology, University Hospital 'Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi', Varese, Italy., Kazakbaeva K; Republician Specilized Scientific and Practical Medical Centre of Hematology, Tashkent, Uzbekistan., Saliev S; Republician Specilized Scientific and Practical Medical Centre of Hematology, Tashkent, Uzbekistan., Abulafia AS; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel., Al-Kindi S; Department of Haematology, Sultan Qaboos University, Muscat, Oman., Byrne J; Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, England, UK., Robertson HF; Centre for Haematology, Imperial College London, London, UK., Cerrano M; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy., Shmakov R; FSBI «National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov» Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation., Polushkina E; FSBI «National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov» Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation., de Fabritiis P; Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy., Trawinska MM; Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy., Abruzzese E; Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy.

Publikováno v: Leukemia [Leukemia] 2024 Nov; Vol. 38 (11), pp. 2514.

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.

Autor: Crisà E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. elena.crisa@ircc.it.; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy. elena.crisa@ircc.it., Mora E; Hospital Universitario y Politécnico La Fe, Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Germing U; Department of Hematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Bally C; Hématologie clinique, hôpital Necker. Assistance publique hôpitaux de Paris (APHP), Paris, France., Diez Campelo M; Hematology, Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Salamanca, Spain., Myllymäki M; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Jädersten M; Department of Hematology M64 Karolinska University Hospital, Stockholm, Sweden., Komrokji R; Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL, USA., Platzbecker U; Department of Hematology, Cellular Therapy,Hemostaseology and Infectiology, University Hospital Leipzig, Leipzig, Germany., Haase D; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Hofmann WK; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Heidelberg, Germany., Al Ali NH; Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL, USA., Barraco D; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Dipartimento di Ematologia - ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy., Bargay JJ; Hematology Department. Hospital Son Llatzer, Mallorca, Spain., Bernal T; Hematology Department. Hospital Central de Asturias, Oviedo, Spain., López Cadenas F; Hematology Department. Hospital Clinico Universitario de Salamanca, Salamanca, Spain., Calvisi A; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; UOC Ematologia CTMO, Osp San Francesco Nuoro, Nuoro, Italy., Capodanno I; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; SOC Ematologia Azienda USL-IRCSS di Reggio Emilia, Reggio Emilia, Italy., Cerrano M; Hematology-University Hospital Città della Salute e della Scienza, Turin, Italy.; Hematology- Hospital Città della Salute e della Scienza, Turin, Italy., Ciancia R; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; IRCCS Centro di Riferimento Oncologico (CRO) di Aviano (Pordenone), Aviano, Italy., Crugnola M; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Hematology Unit and BMT center University Hospital of Parma, Parma, Italy., Kündgen A; Department of Hematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Finelli C; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Institute of Hematology 'Seràgnoli', Bologna, Italy., Fozza C; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy., Frairia C; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Hematology- Hospital Città della Salute e della Scienza, Turin, Italy., Freja E; Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland., Ganster C; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Kubasch AS; Department of Hematology, Cellular Therapy,Hemostaseology and Infectiology, University Hospital Leipzig, Leipzig, Germany., Jimenez MJ; Hematology Department. Hospital Gemans Trias i Pujol, Badalona, Spain., Latagliata R; Unità Operativa Complessa (UOC) Ematologia, Ospedale Belcolle, Viterbo and Division of Cellular Biotechnology and Hematology, Sapienza University, Rome, Italy., Hernandez Mohedo F; Hematology Department. Hopital Unversitario Virgen de las Nieves, Granada, Spain., Molero A; Hematology Department. Hospital Universitario Vall D'Hebron, Barcelona, Spain., Vara Pampliega M; Hematology Department. Hospital de Cruces, Barakaldo, Spain., Perez CA; Hematology Department. Hospital Universitario Reina Sofia, Cordoba, Spain., Pietrantuono G; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; IRCCS CROB, Referral Cancer Center of Basilicata, Rionero In Vulture, Italy., Poloni A; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Hematology, Università Politecnica Marche - AOU Marche, Ancona, Italy., Pomares H; Hematology Department. ICO Duran i Reynals, L'Hospitalet de LLobregat, LLobregat, Spain., Recasens V; Valle Recasens. Hematology Department. Hospital Miguel Servent, Zaragoza, Spain., Rüfer A; Division of Hematology, Luzerner Kantonsspital-in association with University Luzern, Luzern, Switzerland., Signori A; Department of Health Sciences - Section of Biostatistics University of Genoa, Genova, Italy., Hellstrom-Lindberg E; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Sanz G; Hematology, Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Salamanca, Spain.; CIBERONC, ISCIII, Madrid, Spain., Santini V; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy. valeria.santini@unifi.it.; MDS Unit, Hematology, DMSC, AOU Careggi, University of Florence, Florence, Italy. valeria.santini@unifi.it.

Publikováno v: Leukemia [Leukemia] 2024 Oct; Vol. 38 (10), pp. 2259-2265. Date of Electronic Publication: 2024 Aug 05.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Equilibrium hydrostatic equation and Newtonian limit of the singular f(R) gravity

Autor: Bustelo, A. J., Barraco, D. E.

Publikováno v: Class.Quant.Grav.24:2333-2342,2007

We derive the equilibrium hydrostatic equation of a spherical star for any gravitational Lagrangian density of the form $L=\sqrt{-g}f(R)$. The Palatini variational principle for the Helmholtz Lagrangian in the Einstein gauge is used to obtain the fie

Externí odkaz: http://arxiv.org/abs/gr-qc/0611149

Lithium titanate as anode material for lithium ion batteries: Synthesis, post-treatment and its electrochemical response

Autor: Chauque, S., Oliva, F.Y., Visintin, A., Barraco, D., Leiva, E.P.M., Cámara, O.R.

Publikováno v: In Journal of Electroanalytical Chemistry 15 August 2017 799:142-155